Aclaris Therap

Forecast & Rating11 analysts currently cover Aclaris Therap, with about 90.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $10.00, about 82.5% upside from the current price of $5.48. Price targets range from $4.00 to $16.00 — a wide spread, showing clear disagreement over just how much Aclaris Therap can rise. Historically, about 26.1% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Aclaris Therap closely still see room for the stock to rise. Data as of Jul 16, 2026; for reference only and not investment advice.